Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/21 18:31 | 8/9/21 | LOGC | Health | BioPrd | Biological Products, (No Diag | Gruskin Daniel | MA | O | Chief Me | S.d | -6 | 4.35 | 0 | -1 | -31 | 3 | D | ||||||||||||||
4/19/21 21:00 | 4/16/21 | LOGC | Health | BioPrd | Biological Products, (No Diag | Chiang Kyle | MA | O | COO | S.d | -17 | 5.73 | 0 | -3 | -11 | 23 | D | ||||||||||||||
4/19/21 21:00 | 4/16/21 | LOGC | Health | BioPrd | Biological Products, (No Diag | Chereau Frederic | MA | DO | P,Chief | S.d | -43 | 5.73 | 0 | -8 | -3 | 254 | D | ||||||||||||||
10/5/20 17:00 | 7/16/20 | LOGC | Health | BioPrd | Biological Products, (No Diag | Arix Bioscience Plc | X0 | T | S.m | -4,599 | 7.70 | 0 | -598 | -20 | 2,381 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |